These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24251882)

  • 21. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.
    Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ;
    J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A brief history of artemisinin: Modes of action and mechanisms of resistance.
    Lu F; He XL; Richard C; Cao J
    Chin J Nat Med; 2019 May; 17(5):331-336. PubMed ID: 31171267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data.
    WWARN Gametocyte Study Group
    BMC Med; 2016 May; 14():79. PubMed ID: 27221542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of the In Vivo MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria.
    Hien TT; White NJ; Thuy-Nhien NT; Hoa NT; Thuan PD; Tarning J; Nosten F; Magnusson B; Jain JP; Hamed K
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying the pharmacology of antimalarial drug combination therapy.
    Hastings IM; Hodel EM; Kay K
    Sci Rep; 2016 Sep; 6():32762. PubMed ID: 27604175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
    Saralamba S; Pan-Ngum W; Maude RJ; Lee SJ; Tarning J; Lindegårdh N; Chotivanich K; Nosten F; Day NP; Socheat D; White NJ; Dondorp AM; White LJ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):397-402. PubMed ID: 21173254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing the antimalarial activity of artesunate.
    Adebayo JO; Tijjani H; Adegunloye AP; Ishola AA; Balogun EA; Malomo SO
    Parasitol Res; 2020 Sep; 119(9):2749-2764. PubMed ID: 32638101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure.
    Witmer K; Dahalan FA; Delves MJ; Yahiya S; Watson OJ; Straschil U; Chiwcharoen D; Sornboon B; Pukrittayakamee S; Pearson RD; Howick VM; Lawniczak MKN; White NJ; Dondorp AM; Okell LC; Chotivanich K; Ruecker A; Baum J
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination.
    Ouji M; Augereau JM; Paloque L; Benoit-Vical F
    Parasite; 2018; 25():24. PubMed ID: 29676250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for artemisinin-resistant malaria.
    Koehne E; Adegnika AA; Held J; Kreidenweiss A
    Expert Opin Pharmacother; 2021 Dec; 22(18):2483-2493. PubMed ID: 34311639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
    Blasco B; Leroy D; Fidock DA
    Nat Med; 2017 Aug; 23(8):917-928. PubMed ID: 28777791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria.
    Wattanakul T; Baker M; Mohrle J; McWhinney B; Hoglund RM; McCarthy JS; Tarning J
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parasite Viability as a Measure of
    Radohery GFR; Walz A; Gumpp C; Cherkaoui-Rbati MH; Gobeau N; Gower J; Davenport MP; Rottmann M; McCarthy JS; Möhrle JJ; Rebelo M; Demarta-Gatsi C; Khoury DS
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0011422. PubMed ID: 35727057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage.
    Kümpornsin K; Loesbanluechai D; de Cozar C; Kotanan N; Chotivanich K; White NJ; Wilairat P; Gomez-Lorenzo MG; Gamo FJ; Sanz LM; Lee MCS; Chookajorn T
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():186-190. PubMed ID: 34673330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
    Dini S; Zaloumis S; Cao P; Price RN; Fowkes FJI; van der Pluijm RW; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimalarial Drug Resistance: A Threat to Malaria Elimination.
    Menard D; Dondorp A
    Cold Spring Harb Perspect Med; 2017 Jul; 7(7):. PubMed ID: 28289248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating Pharmacokinetic-Pharmacodynamic Modeling and Physiologically Based Pharmacokinetic Modeling to Optimize Human Dose Predictions for Plasmodium falciparum Malaria: a Chloroquine Case Study.
    Redhi D; Mulubwa M; Gibhard L; Chibale K
    Antimicrob Agents Chemother; 2023 May; 67(5):e0134522. PubMed ID: 37010410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrrolidine-Acridine hybrid in Artemisinin-based combination: a pharmacodynamic study.
    Pandey SK; Biswas S; Gunjan S; Chauhan BS; Singh SK; Srivastava K; Singh S; Batra S; Tripathi R
    Parasitology; 2016 Sep; 143(11):1421-32. PubMed ID: 27230403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.